M&A Activity
The latest mergers, acquisitions, and strategic partnerships transforming the cannabis sector.
M&A Activity · page 3
- Industry Trends
Is a Cannabis M&A Tidal Wave on the Way?
At the end of the month (March 30, 2026), shareholders of one of the fastest growing Canadian licenced producers, Organigram Global, will convene to decide the fate of its proposed €250m acquisition of Sanity Group.
- Cultivation
Business Brief: Canify and MG Health Announce Merger
German pharmaceutical cannabis company Canify AG and African medical cannabis cultivator MG Health Limited have announced a planned merger, marking yet another M&A deal in a market widely expected to see an incoming wave of consolidation.
- Industry Trends
The Scramble for Europe
Last month, the German cannabis market saw its most significant consolidation deal to date, as Canadian heavyweight Organigram announced plans to acquire Sanity Group in a deal worth up to €250m.
- M&A Activity
Curaleaf Laboratories and Sanity Group Announce Partnership to Advance Medical Cannabis Innovation in the UK
Curaleaf Laboratories, one of the UK-leading pharmaceutical-grade medical cannabis manufacturers, is delighted to announce a partnership with Berlin-based Sanity Group, a European life science company focused on cannabinoids and wellbeing products.
- M&A Activity
Business Brief: Argent Biopharma’s Revenues Drop, Outgoings Rise Ahead of AusCann Deal
Argent Biopharma, formerly MGC Pharmaceuticals, has entered 2026 in a precarious financial position, according to its recently published quarterly figures.
- Industry Trends
AI: The Last Refuge of the Failed Cannabis Company
Late last month, NASDAQ-listed cannabis operator Flora Growth, which once operated one of Colombia’s largest outdoor cultivation facilities, became the latest to exit the cannabis industry, rebranding as an AI-focused digital asset firm ZeroStack Corp.
- Investment & Finance
From Courtrooms to Boardrooms: 2026 Consolidation Accelerates as Cannabis Companies Merge, Battle and Partner
The global cannabis industry barely had time to catch its breath over the Christmas break, following several seismic developments at the tail end of the year.
- Investment & Finance
Real Estate, Banking, and Bankruptcy: Q3 Hits the Three Tiers of Cannabis Capital Very Differently
The story of the cannabis sector’s financial health is increasingly split between those providing the capital and those who desperately need it.
- Clinical Research
Evidence, Earnings and Expansion: Avextra Enrolls its First Patient to Landmark Italian Clinical Trial, as Market Leaders Wrangle to Maintain Dominance
The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our understanding of its use cases, and more importantly, fill the long-maligned gap in clinical evidence.
- M&A Activity
Barney’s Farm Terminates Landmark Merger With Sensi Seeds & Ilgm Amid Accusations of Failed Payments
Dutch seed bank Barney’s Farm, one of the leading names in the global consumer cannabis seeds market, has backed out of a landmark merger with Sensi Seeds and US firm I Love Growing Marijuana (ILGM).
- M&A Activity
Grow Group’s Avida Acquisition Marks Bold Step Forward for UK Cannabis Stalwart
Grow Group, one of the UK’s leading medical cannabis distributors now supplying over 10,000 patients internationally, announced a major strategic shift to bring control of its operations entirely in house.
